Low-dose Zoladex to be pulled from shelves In a move labelled a ‘backwards step in gender equity’, AstraZeneca will pull the 3.6 mg implant from Australian markets in November.
Higher rebates needed to support epilepsy care: RACGP Amid limited access to neurologists, red tape and long wait times, a college submission says GPs must be better supported.
Hantavirus travellers return: What GPs should know Six passengers are now quarantining in Australia – what does this mean for GPs and what should they do to prepare?
Study reinforces regular GPs’ role in reducing hospital admissions It found older patients with a usual GP are up to 28% less likely to visit an ED, but systems must support long-term relationships.